INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role
(Thomson Reuters ONE) -
Industry expert Clare Grace to head efforts to build stronger relationships for
better engagement with clinical research sites and patients across the globe
Raleigh, N.C., Oct. 1, 2014 - INC Research, a leading, global Phase I to IV
contract research organization (CRO), today announced Clare Grace, PhD, has
joined the Company as Vice President, Site and Patient Access. In this new
global leadership role, Dr. Grace will further develop and enhance the
execution of INC Research's vision to create stronger connections with high-
performance clinical research sites and targeted patient populations. Dr. Grace
brings nearly 20 years of strategic global clinical research leadership to the
Company, including senior positions within the academic, pharmaceutical, biotech
and CRO industries.
"Sites play such a critical in role in providing the real-world link between the
drug development process and patients," said Alistair Macdonald, Chief Operating
Officer. "INC Research understands the value sites bring to clinical research
and is committed to enhancing our relationships with them to ultimately help
bring new treatments to market more efficiently. We are very pleased to have
Clare leading the team to execute on our vision of connecting at a deeper level
with these key stakeholders and communities for mutually beneficial outcomes."
In her new role at INC Research, Dr. Grace will serve as the key advocate for
sites and patients through several core focus areas, including developing
strategic relationships with patient advocacy organizations and site management
organizations (SMOs); implementing new and innovative approaches to work more
effectively with sites; and streamlining operational functions to drive
delivery, quality and efficiency.
"Establishing more meaningful relationships with clinical research sites and
patients is critical to our ability to deliver new medicines to market," said
Dr. Grace. "We recognize that each trial and patient have specific needs and
will work tirelessly to provide a personalized approach to meet these needs."
Dr. Grace joins INC Research from PPD where she held several leadership roles,
including Senior Director and Head of Global Site Intelligence, Director of
Strategic Site Collaborations, and several project management positions in the
oncology therapeutic area. Prior to PPD, she held clinical development roles
with AstraZeneca and Antisoma. Dr. Grace holds a PhD in Molecular Oncology from
the University of Manchester Institute of Science and Technology and a
bachelor's degree in applied biochemistry from Liverpool John Moores University,
both in England.
Dr. Grace will be among other executives from INC Research attending the Society
for Clinical Research Sites' (SCRS) annual Site Solutions Summit Oct. 10-12 on
Amelia Island, Fla. to further engage with sites on how to improve the clinical
development process. She is scheduled to speak Oct. 11 at 4:45 p.m. on "New
Technologies: How Will They Affect My Site?". INC Research is a Global Impact
Partner with SCRS and a finalist for the 2014 SCRS Eagle Award recognizing
outstanding leadership, professionalism, integrity, passion and dedication to
advancing the clinical research profession through a strong site partnership.
To learn more about INC Research's site and patient engagement programs or to
participate in current studies, please visit www.incresearch.com/how-we-
work/site-relationships.
About INC Research
INC Research is a leading global contract research organization (CRO) providing
the full range of Phase I to Phase IV clinical development services for
the biopharmaceutical and medical device industry. Leveraging the breadth of our
service offerings and the depth of our therapeutic expertise across multiple
patient populations, INC Research connects customers, clinical research sites
and patients to accelerate the delivery of new medicines to market. We were
ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global
Investigative Site Relationship Survey. INC Research is headquartered in
Raleigh, NC, with operations across six continents and experience spanning more
than 100 countries.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via GlobeNewswire
[HUG#1859849]
Unternehmensinformation / Kurzprofil:
Datum: 01.10.2014 - 16:00 Uhr
Sprache: Deutsch
News-ID 342621
Anzahl Zeichen: 5207
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 130 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
